AIM:KMK · Industrials · Radiation detection and bio-detection technology for advanced imaging (medical/security/industrial) and CBRN (Chemical, Biological, Radiological, Nuclear) detection markets

Kromek Group plc

Kromek Group plc is a UK-headquartered (County Durham) developer and manufacturer of radiation detection and bio-detection technology, based on proprietary cadmium zinc telluride (CZT) and associated material science. It operates two reporting segments: Advanced Imaging (CT/SPECT medical imaging detector components, security and industrial screening) and CBRN Detection (nuclear, radiological, chemical and biological-threat detection for government/defence customers). It has manufacturing operations in the UK and US and sells into 40+ countries.

Export the Kromek Group plc factsheetfree account Open the FY2026 report

AIM:KMKClose, 16 Oct 2026

+1.8% on the day−13.8% over a year

Market cap£36.7m
52-week range5.5p – 12.6p
Price / earnings50.1×
Free cash flow yield−5.1%
Shares traded a day1.4m

Prices to 16 Oct 2026 · ratios on the FY2026 accounts · not investment advice

The company

Admitted16 Oct 2013
Registered officeNETPark, Thomas Wright Way, Sedgefield, TS21 3FD, United Kingdom
IncorporatedUnited Kingdom
Employees160
Reports inGBP
Companies House08661469
Websitekromek.com
Chief executiveDr Arnab Basu MBE DL
Finance directorMs Claire Burgess
ChairMr Rakesh Sharma OBE FREng CPhys
AuditorHaysMac LLPclean opinion in all 11 reports read · going-concern uncertainty in 1 · 3 changes of auditor
Adviser and brokerCavendish Capital Markets Ltd (Nominated Adviser and Broker)
Next annual reportExpected 18 Sept 2027for the year to 30 Apr 2027

Share price and financials

5.6p at close on 16 Oct 2026 · 12 reported years, FY2015–FY2026

Years in viewFY2015 – FY2027

16 Oct 20265.6p−83.4% since 4 Jan 2016 1.0m traded

5.6p

Line	FY2015locked	FY2016locked	FY2017locked	FY2018locked	FY2019locked	FY2020locked	FY2021locked	FY2022locked	FY2023locked	FY202404/24	FY202604/26
Revenue	30.2	22.8	23.7	34.8	31.0	29.1	27.0	23.6	14.1
Gross profit	21.6	9.6	15.8	22.2	19.1	14.6	14.1	11.9	19.0
Operating profit	2.3	2.3	1.9	2.5	4.0	3.4	2.0	2.2	3.7
Adjusted operating profit	3.2	4.4	2.1	3.3	2.7	1.8	2.5	4.1	2.7		—
Exceptional items	0.17	0.16	0.07	0.12	0.12	0.12	0.10	0.14	0.13		—
Net finance cost	1.1	1.6	1.8	0.80	0.76	1.5	1.2	1.3	1.0
Profit before tax	3.0	2.4	3.0	1.8	4.1	3.3	3.1	3.3	3.6
Tax charge	(0.52)	(0.92)	(1.1)	(1.3)	(0.67)	(0.89)	(0.94)	(1.1)	(1.1)
Profit for the year	2.1	2.3	1.7	1.5	1.6	3.6	1.6	2.1	3.4
EBITDA	5.3	5.7	6.0	7.7	6.2	4.7	6.2	5.7	7.0
Basic EPS	0.49p	0.26p	0.56p	0.47p	0.54p	0.50p	0.42p	0.34p	0.43p
Diluted EPS	0.60p	0.59p	0.29p	0.46p	0.50p	0.59p	0.31p	0.43p	0.49p
Adjusted EPS	0.48p	0.47p	0.59p	0.52p	0.54p	0.43p	0.61p	0.27p	0.31p	—
Dividend per share	0.00p	0.00p	0.00p	0.00p	0.00p	0.00p	0.00p	0.00p	0.00p	—

GBP millions, negatives in brackets. Per-share lines in pence. later is what a following report restated the figure to; vs is a second reading that disagrees. The figure shown is the one the original filing printed, and both readings are kept. Click any figure: opens the report page it was read from, highlighted; shows how it was calculated. The share price above is drawn to the same columns: each close sits over the financial year it fell in.

2 figures

3 years, at a glance

GBP · %

Dashed: Operating margin, in % on its own scale — read its shape, not its height against the bars.

FY2026Revenue£27.1mOperating margin10.7%